tiprankstipranks
Trending News
More News >
CytoDyn (CYDY)
OTHER OTC:CYDY
US Market

CytoDyn (CYDY) Ratios

Compare
687 Followers

CytoDyn Ratios

CYDY's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, CYDY's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.10 0.25 0.13 0.09 0.23
Quick Ratio
0.10 0.25 0.13 0.09 0.09
Cash Ratio
0.06 0.17 0.04 0.02 0.03
Solvency Ratio
-0.30 0.03 -0.39 -0.66 -2.33
Operating Cash Flow Ratio
-0.20 -0.12 -0.13 -0.21 -0.63
Short-Term Operating Cash Flow Coverage
-0.64 -0.32 -0.37 -0.73 -2.14
Net Current Asset Value
$ -99.64M$ -96.21M$ -117.08M$ -109.99M$ -95.14M
Leverage Ratios
Debt-to-Assets Ratio
3.05 1.51 2.70 3.14 1.26
Debt-to-Equity Ratio
-0.23 -0.28 -0.26 -0.32 -0.39
Debt-to-Capital Ratio
-0.29 -0.40 -0.35 -0.48 -0.64
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 >-0.01 0.00
Financial Leverage Ratio
-0.07 -0.19 -0.10 -0.10 -0.31
Debt Service Coverage Ratio
-1.14 0.27 -0.47 -0.90 -3.04
Interest Coverage Ratio
-5.19 2.33 -2.08 -1.61 -1.37
Debt to Market Cap
0.08 0.07 0.19 0.16 0.16
Interest Debt Per Share
0.02 0.03 0.04 0.07 0.13
Net Debt to EBITDA
-2.05 1.79 -1.50 -0.81 -0.17
Profitability Margins
Gross Profit Margin
0.30%0.30%0.00%0.00%80.08%
EBIT Margin
595.88%-145.39%0.00%0.00%-73591.73%
EBITDA Margin
595.61%-145.69%0.00%0.00%-72386.47%
Operating Profit Margin
316.75%-191.41%0.00%0.00%-27035.34%
Pretax Profit Margin
656.88%-63.30%0.00%0.00%-79255.64%
Net Profit Margin
656.88%-63.30%0.00%0.00%-108331.95%
Continuous Operations Profit Margin
656.88%-63.30%0.00%0.00%-79255.64%
Net Income Per EBT
100.00%100.00%100.00%100.00%136.69%
EBT Per EBIT
207.38%33.07%276.01%196.73%293.16%
Return on Assets (ROA)
-155.91%20.75%-447.57%-706.91%-987.37%
Return on Equity (ROE)
22.25%-3.90%42.69%72.90%305.26%
Return on Capital Employed (ROCE)
31.01%-21.58%24.72%37.40%76.52%
Return on Invested Capital (ROIC)
142.68%-45.06%41.89%63.80%170.65%
Return on Tangible Assets
-155.91%20.75%-447.57%-706.91%-991.85%
Earnings Yield
-6.22%0.92%-32.25%-36.46%-125.21%
Efficiency Ratios
Receivables Turnover
0.00 -2.96 0.00 0.00 0.00
Payables Turnover
<0.01 <0.01 <0.01 <0.01 <0.01
Inventory Turnover
0.00 0.00 0.00 0.00 <0.01
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.44
Asset Turnover
-0.66 -0.33 0.00 0.00 <0.01
Working Capital Turnover Ratio
0.09 0.09 0.00 0.00 >-0.01
Cash Conversion Cycle
-304.35K -298.04K -372.06K -130.83K -344.65K
Days of Sales Outstanding
0.00 -123.39 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 123.47K
Days of Payables Outstanding
304.35K 297.92K 372.06K 130.83K 468.12K
Operating Cycle
0.00 -123.39 0.00 0.00 123.47K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.01 >-0.01 -0.01 -0.03 -0.11
Free Cash Flow Per Share
-0.01 >-0.01 -0.01 -0.03 -0.11
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-15.74 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-0.64 -0.32 -0.37 -0.71 -2.11
Operating Cash Flow to Sales Ratio
2.94 1.48 0.00 0.00 -292.19
Free Cash Flow Yield
-4.87%-2.14%-7.11%-11.47%-33.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.76 109.11 -3.10 -2.74 -0.80
Price-to-Sales (P/S) Ratio
-57.77 -69.07 0.00 0.00 865.21
Price-to-Book (P/B) Ratio
-2.84 -4.25 -1.32 -2.00 -2.44
Price-to-Free Cash Flow (P/FCF) Ratio
-19.62 -46.62 -14.07 -8.72 -2.96
Price-to-Operating Cash Flow Ratio
-19.55 -46.62 -14.07 -8.72 -2.96
Price-to-Earnings Growth (PEG) Ratio
0.11 -1.05 0.07 0.04 -0.02
Price-to-Fair Value
-2.84 -4.25 -1.32 -2.00 -2.44
Enterprise Value Multiple
-10.33 49.20 -10.07 -6.23 -1.36
Enterprise Value
376.22M 424.07M 181.51M 251.79M 262.71M
EV to EBITDA
-22.43 49.20 -10.07 -6.23 -1.36
EV to Sales
-63.59 -71.68 0.00 0.00 987.64
EV to Free Cash Flow
-22.59 -48.38 -16.53 -10.03 -3.38
EV to Operating Cash Flow
-22.59 -48.38 -16.53 -10.03 -3.38
Tangible Book Value Per Share
-0.09 -0.08 -0.12 -0.13 -0.14
Shareholders’ Equity Per Share
-0.09 -0.08 -0.12 -0.13 -0.14
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 -0.16 -0.37
Revenue Per Share
>-0.01 >-0.01 0.00 0.00 <0.01
Net Income Per Share
-0.03 <0.01 -0.05 -0.10 -0.43
Tax Burden
1.00 1.00 1.00 1.00 1.37
Interest Burden
1.25 0.44 2.76 1.97 1.08
Research & Development to Revenue
-1.75 -2.86 0.00 0.00 101.67
SG&A to Revenue
-1.25 -1.23 0.00 0.00 166.55
Stock-Based Compensation to Revenue
-0.18 -0.27 0.00 0.00 23.55
Income Quality
0.79 -2.34 0.22 0.31 0.37
Currency in USD